Companies / 10634
BioLife
| id | 10634 |
|---|---|
| name | BioLife |
| category_id | 9 |
| sector | — |
| website | — |
| description | Repligen acquired BioLife, a Bothell-based cell and gene therapy tools maker, for $1.5B ($11.25 cash plus 0.1442 shares per BioLife share... |
| founded_year | — |
| hq_country | US |
| region | — |
| country_code | US |
| ticker | — |
| exchange | — |
| is_public | false |
| founding_country | — |
| naics_code | — |
| naics_description | — |
| firm_type | — |
| is_hbcu | false |
| is_divine_nine | false |
| is_international | false |
| roles | [] |
| sec_cik | — |
| sec_edgar_url | — |